loader

AbbVie

NYSE:ABBV
Featured Articles and Interviews

Alzheimer’s Disease Treatment Stocks: 3 Biggest NASDAQ Companies

5 Biggest Pharmaceutical ETFs in 2025

Press Releases

Health Canada Approves AbbVie's RINVOQ® for the Treatment of Adults with Active Non-Radiographic Axial Spondyloarthritis

AbbVie Releases New Data Demonstrating Breadth of Its Gastroenterology Portfolio at 2023 Digestive Disease Week®

AbbVie’s VENCLEXTA Gets Health Canada Approval to Treat CLL

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

Interactive Chart

×